Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells.
OBJECTIVE: The binding of FasL (CD95L) to its receptor, Fas (CD95), induces apoptosis. Studies have shown that in patients with rheumatoid arthritis (RA), T lymphocytes are resistant to FasL-induced apoptosis in vivo but are susceptible to FasL-induced apoptosis in vitro. Dysfunction in this mechan...
Հիմնական հեղինակներ: | Tarr, J, Winyard, P, Ryan, B, Harries, L, Haigh, R, Viner, N, Eggleton, P |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
2010
|
Նմանատիպ նյութեր
-
Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis
: A. Berdeli, և այլն
Հրապարակվել է: (2012-12-01) -
The Fas/FasL System in Reproduction: Survival and Apoptosis
: Gil Mor, և այլն
Հրապարակվել է: (2002-01-01) -
A mechanism of release of calreticulin from cells during apoptosis.
: Tarr, J, և այլն
Հրապարակվել է: (2010) -
Alteration of Regulation of Fas/FasL Mediated Apoptosis in Gastric Cancer
: Reggie García Robles, և այլն
Հրապարակվել է: (2009-04-01) -
Leucemia mielóide crônica e o sistema Fas-FasL Chronic myeloid leukemia and the Fas-FasL system
: Ana Paula F. Bergantini, և այլն
Հրապարակվել է: (2005-06-01)